CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP 0.12 % — DIN 02432579
CHLORHEXIDINE GLUCONATE : 0.12 % · XTTRIUM LABORATORIES INC. · LIQUID ; MOUTHWASH/GARGLE · wholesale supply in Canada
Health Canada status: APPROVED
What is CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP?
CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP 0.12 % contains CHLORHEXIDINE GLUCONATE : 0.12 %. It is listed in the Health Canada Drug Product Database under DIN 02432579, held by XTTRIUM LABORATORIES INC., supplied as LIQUID ; MOUTHWASH/GARGLE for ORAL administration. Health Canada currently lists it as approved, status dated 10-Oct-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP used for?
Treatment of moderate to severe gingivitis, and management of associated gingival bleeding and inflammation between dental visits.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Chlorhexidine cost around the world?
Chlorhexidine is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Morocco publishes a PPV (public price); Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 2 | 7 | USD███.██ |
| South Africa | single exit price | 4 | 4 | ZAR███.██ |
| Morocco | PPV (public price) | 2 | 3 | MAD███.██ |
| Australia | ex-manufacturer | 2 | 2 | AUD███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
17 pack listings across 11 brand entries and 5 price bases, refreshed 08 Sep 2026. Ranges span every Chlorhexidine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Chlorhexidine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
13 holders have a Canadian DIN containing Chlorhexidine, across 19 DINs, of which 8 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PHARMASCIENCE INC | 3 | 2 | PMS-CHLORHEXIDINE, PMS-CHLORHEXIDINE WITHOUT ALCOHOL, X-PUR CHLORHEXIDINE | Sourceable in Canada |
| GERMIPHENE CORPORATION | 2 | 2 | ORO CLEAR, ORO-CLENSE | Sourceable in Canada |
| COLGATE-PALMOLIVE CANADA INC | 3 | 1 | PERIOGARD, PERIOGARD ALCOHOL FREE | Sourceable in Canada |
| EURO-PHARM INTERNATIONAL CANADA INC | 2 | 1 | CHLORHEXIDINE ALCOHOL FREE, EURO-CHLORHEXIDINE | Sourceable in Canada |
| 3M HEALTHCARE CANADA COMPANY LIMITED | 1 | 1 | PERIDEX ORAL RINSE | Sourceable in Canada |
| CHX TECHNOLOGIES INC | 1 | 1 | PREVORA STAGE 1 | Sourceable in Canada |
| AMD MEDICOM INC | 1 | 0 | DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% | No marketed DIN |
| BAJAJ MEDICAL, LLC | 1 | 0 | CHLORHEXIDINE | No marketed DIN |
| PDT IMAGE INC. DBA PRO-DENTEC CANADA | 1 | 0 | PRO-DENTX CHLORHEXIDENE ORAL RINSE | No marketed DIN |
| PROCTER & GAMBLE INC | 1 | 0 | PERIDEX ORAL RINSE 0.12% | No marketed DIN |
| SAGE PRODUCTS LLC | 1 | 0 | CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP | No marketed DIN |
| SUNSTAR AMERICAS INC | 1 | 0 | GUM PAROEX | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.12 % |
|---|---|
| Dosage form | LIQUID ; MOUTHWASH/GARGLE |
| Route | ORAL |
| Pack configuration (monograph) | 1-oz (15 mL) and 16-oz (473 mL) amber plastic bottles with child-resistant dispensing closures. |
| Storage | Preserve in tight containers, protected from light, at controlled room temperature (15°C to 30°C). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Chlorhexidine |
|---|---|
| ATC code | A01AB03 |
| AHFS class | 52:04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02432579 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2432579 |
| Brand name | CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP |
| Generic / active ingredient | CHLORHEXIDINE GLUCONATE : 0.12 % |
| Market authorization holder | XTTRIUM LABORATORIES INC. |
| Health Canada schedule | Prescription |
| ATC code | A01AB03 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A01AB |
| Current status | APPROVED |
| Status date | 10-Oct-2014 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Twice daily oral rinsing for 30 seconds (15 mL undiluted) after toothbrushing. Expectorate after rinsing. Avoid eating/drinking for 30 minutes after use.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to chlorhexidine gluconate or other formula ingredients.
Warnings and precautions
May cause staining of teeth/restorations and taste alteration. Not for periodontitis treatment. Rare cases of permanent taste alteration or restoration replacement reported.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
8 of 19 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| EURO-CHLORHEXIDINE | 0.12 % | MOUTHWASH | EURO-PHARM INTERNATIONAL CANADA INC | MARKETED | 02462842 |
| ORO CLEAR | 0.12 % | MOUTHWASH | GERMIPHENE CORPORATION | MARKETED | 02291096 |
| ORO-CLENSE | 0.12 % | MOUTHWASH | GERMIPHENE CORPORATION | MARKETED | 02209055 |
| PERIDEX ORAL RINSE | 0.12 % | MOUTHWASH | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | 02237452 |
| PERIOGARD ALCOHOL FREE | 0.12 % | SOLUTION | COLGATE-PALMOLIVE CANADA INC | MARKETED | 02405091 |
| PMS-CHLORHEXIDINE | 0.12 % | MOUTHWASH | PHARMASCIENCE INC | MARKETED | 02240433 |
| PMS-CHLORHEXIDINE WITHOUT ALCOHOL | 0.12 % | MOUTHWASH | PHARMASCIENCE INC | MARKETED | 02493160 |
| PREVORA STAGE 1 | 10 % | SOLUTION ; KIT | CHX TECHNOLOGIES INC | MARKETED | 02046245 |
| CHLORHEXIDINE | 0.12 % | MOUTHWASH | BAJAJ MEDICAL, LLC | CANCELLED (UNRETURNED ANNUAL) | 02242329 |
| CHLORHEXIDINE ALCOHOL FREE | 0.12 % | MOUTHWASH | EURO-PHARM INTERNATIONAL CANADA INC | CANCELLED POST MARKET | 02463032 |
2 · Same class — other molecules in ATC A01AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Chlorhexidine | CHLORHEXIDINE · CHLORHEXIDINE ALCOHOL FREE · CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP · DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% · +13 more | 19 | 8 | Yes |
| Doxycycline | ATRIDOX · JAMP DOXYCYCLINE · PMS-DOXYCYCLINE | 4 | 2 | Yes |
| Minocycline | ARESTIN MICROSPHERES | 1 | 1 | Yes |
| Domiphen | ANTISEPTIQUE PASTILLE 1.5MG CERISE · ANTISEPTIQUE PASTILLE 1.5MG CITRON · ANTISEPTIQUE PASTILLE 1.5MG MENTHE · ANTISEPTIQUE PASTILLE 1.5MG MIEL EUCALYPTUS · +8 more | 12 | 0 | Not in Canada |
| Various | BABY'S OWN TEETHING GEL - 2.5% · CAMPHORATED PARA CHLOROPHENOL LIQ · ENDOPEROX 100% · ROOT CANAL THERAPY | 4 | 0 | Not in Canada |
| Hydrogen Peroxide | ORAJEL PERIOSEPTIC RINSE - 1.5% · PERIOSELECT HYDROGEN PEROXIDE SOLUTION 1.7% | 2 | 0 | Not in Canada |
| Hexetidine | STERI/SOL LIQUID | 1 | 0 | Not in Canada |
| Antiinfectives For Local Oral Treatment | BISCO CAVITY CLEANSER LIQ 0.2% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A01AD | Amlexanox · Benzydamine · Epinephrine · Epinephrine, Combinations · Other Agents For Local Oral Treatment · +1 more | 146 | 5 |
| A01AC | Corticosteroids For Local Oral Treatment · Dexamethasone, Combinations * · Prednisolone, Combinations · Triamcinolone | 7 | 1 |
| A01AA | Caries Prophylactic Agents · Combination (Caries Prophylactic Agents) · Sodium Fluoride · Sodium Fluoride, Combinations · Sodium Monofluorophosphate · +2 more | 226 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP called?
The same molecule, Chlorhexidine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| SEPTEAL | Latin | Morocco |
| BUCCOSEPT | Latin | Morocco |
| LAVENTE OINT. | Latin | Saudi Arabia |
| Naseptin | Latin | South Africa |
| Plaqacide | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ask about availability of CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.